Key words: Bile metabolism; cholesterol-7a-hydroxylase; HMG-CoA reductase; hypercholesterolaemia; Background. Chronic renal failure (CRF ) is associated LDL receptor; nephrotic syndrome with an atherogenic lipid profile and an increased risk of ischaemic cardiovascular disease. The associated hyperlipidaemia is reportedly ameliorated by erythropoietin ( Epo) therapy. According to a recent report, rats studied 3 weeks after 5/6 nephrectomy and fed a Introduction high-protein diet exhibited increased activities of hepatic HMG-CoA reductase (HMG-CoAR) and cholChronic renal failure (CRF ) is associated with a high esterol 7a-hydroxylase (Ch-7a-H ), despite normal risk of morbidity and mortality from ischaemic cardiocorresponding mRNA values. vascular disease. This is in part related to the CRFDesign and Methods. This study was designed to examassociated hypertension and dyslipidaemia [1] [2] [3] . ine the eÂects of naturally progressing CRF of longer Hypertriglyceridaemia and elevated plasma very-lowduration as well as those of Epo therapy on gene density lipoprotein ( VLDL) concentration are the most expressions of the key factors involved in hepatic common lipid abnormalities in clinical and expericholesterol metabolism, i.e., LDL receptor (LDLR), mental CRF [4] [5] [6] . These abnormalities are associated HMG-CoAR, and Ch-7a-H. Sprague-Dawley rats with impaired clearance of triglyceride-rich lipoprowere randomized to the CRF group ( 5/6 nephrectomy), teins from the circulation [7] [8] [9] and depressed activities Epo-treated CRF group (given Epo 150 U/kg/twice of lipoprotein lipase (LPL), hepatic lipase (HL), and weekly) and sham-operated, placebo-treated normal lecithin cholesterol acyltransferase ( LCAT ) [10] [11] [12] . controls. They were allowed free access to regular rat In fact recent studies have revealed marked downregulchow and studied 6 weeks after surgery. Liver mRNAs ation of gene expression of LPL, VLDL receptors and and protein mass or activities of the above factors HL in rats with CRF [13] [14] [15] . In contrast to triglycerwere studied.
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ides, changes in plasma total cholesterol concentration Results. Plasma cholesterol concentration was signi-are less frequent in clinical CRF. None the less, ficantly increased in the CRF group (P<0.001) and hypercholesterolaemia occurs in 20% of patients with was modestly lowered (P<0.05) by Epo therapy. end-stage renal disease [5] and very frequently in However, microsomal cholesterol concentration and experimental CRF [6 ] . The precise mechanism of LDLR, HMG-CoAR, and Ch-7a-H mRNA as well as CRF-associated hypercholesterolaemia has not been HMG-CoAR activity, and Ch-7a-H and LDLR pro-fully elucidated. tein mass measurements were virtually identical in the Treatment of CRF anaemia with regular administrathree groups. Thus, hepatic LDLR, HMG-CoAR, and tion of recombinant erythropoietin (Epo) has been Ch-7a-H mRNA and protein measurements in rats shown recently to lower significantly serum triglyceride, with CRF were similar to those of the normal control total cholesterol, and apolipoprotein B concentrations group representing an inappropriate response to the in patients with end-stage renal disease treated with associated hypercholesterolemia. Epo therapy led to either haemodialysis or peritoneal dialysis [16 ] . partial amelioration of CRF-associated hypercholesterThrough coordinate regulation of LDL receptorolaemia with no discernible eÂect on hepatic tissue mediated lipoprotein uptake, cholesterol conversion to expression of the above factors.
bile acids, and endogenous biosynthesis of cholesterol, liver plays an important role in cholesterol metabolism [17, 18] . In an elegant study, Pandak et al. [19] recently reported post-transcriptional upregulations of hepatic weeks post-subtotal nephrectomy as compared to the 1 g of liver by the guanidium thiocyanate extraction procedpair-fed normal control animals. The animals ure as previously described [ 21] . Poly (A)+ RNA was employed in this study were fed a high-protein (35.3%
isolated by Oligo (dT )-cellulose chromatography (Gibco casein-supplemented ) diet to accelerate the course of BRL, Gaithersburg, Maryland, USA). The amount of renal insuÃciency. In addition, the control animals mRNA was determined from the absorbance at 260 nm using were pair-fed with their CRF counterparts. a spectrophotometer. Consequently the faster weight gain normally seen in the control animals as compared to those with CRF cDNA probes was obviated by pair-feeding of the controls in this study. It should be noted, however, that under ordinary
The probe used for Ch-7a-H mRNA is a 2.1 kb cDNA to conditions protein intake is generally reduced (due to rat Ch-7a-H mRNA (a gift from Professor David Russell, CRF-induced anorexia and/or dietary prescription), University of Texas). The probe used for HMG-CoAR and the rate of growth is frequently slowed in subjects mRNA is a 4370 bp cDNA to hamster HMG-CoAR mRNA with CRF. We therefore sought to examine the eÂect ( were washed twice in 2×SSPE/0.5% SDS solution at room to the CRF, Epo-treated CRF ( Epo-CRF), and placebotemperature, twice in 1×SSPE/0.5% SDS solution at 37°C, treated sham-operated normal control groups. The animals and twice in 0.1×SSPE/0.5% SDS solution at 65°C, 15 min assigned to the CRF and CRF-Epo groups underwent a 2/3 each. The washed blots were exposed to the film (New left nephrectomy followed by a right nephrectomy 4 days England Nuclear Research Products) at −80°C for a period later. The procedures were carried out under general anaesof 3-4 h for actin and 2-3 days for HMG-CoAR, Ch-7a-H, thesia (pentobarbitone 50 mg/kg, i.p.) through a dorsal and LDLR. The autoradiographs were scanned with a laser incision. Strict haemostasis and aseptic measures were densitometer (Model PD1211, Molecular Dynamics, observed during surgery. The animals were fed regular rat Sunnyvale, California, USA) to determine relative mRNA chow (Purina Mills Inc., Brentwood, Missouri, USA) and levels. The values obtained for actin were used as internal water ad libitum. The Epo-CRF group received i.p. injections controls. of recombinant human Epo (EpogenA, Amgen Inc., Thousand Oaks, California, USA) 150 U/kg twice weekly for 6 weeks. The dosage used was based on our earlier HMG-CoAR activity and microsomal cholesterol assays studies which demonstrated that the amount given was suÃcient to prevent CRF anaemia in this model [20 ] . The Lysosome-free hepatic microsomes were prepared by diÂer-CRF group received placebo injections of the vehicle instead. ential ultracentrifugation [22] . The protein concentration of Blood pressure was measured by a tail sphygmomanometer microsomal preparations was measured using a Bio-Rad kit ( Harvard Apparatus, South Natick, Massachusetts, USA). (Bio-Rad Laboratories Inc., Hercules, California, USA). The Haematocrit, plasma cholesterol, triglycerides, and creatinine HMG-CoAR activity was determined by the method of concentrations, and urinary creatinine and protein excretion Simonet and Ness [ 23] . Hepatic microsomal cholesterol was were measured using standard laboratory techniques. The extracted and assayed as described previously [ 24] . animals were housed in a thermostatically regulated, lightcontrolled condition with 12-h light ( 500 lux) and dark (<5 lux) cycles.
Ch-7a-H and LDLR protein mass determinations
The Ch-7a-H protein mass was determined by Western blot Isolation of rat liver RNA analysis using a modification of the method described by Chiang et al. [ 25, 26 ] . The Ch-7a-H monoclonal antibody The rats were killed between the hours of 9 and 10 a.m. The liver was removed immediately, snap frozen in liquid nitro-used in these experiments was generously supplied by Professor John Y. L. Chiang, Northwestern Ohio Universities compared with the normal control group. In addition, College of Medicine. LDL protein mass was determined in the CRF group exhibited mild proteinuria and a modhepatic plasma membrane preparation. Hepatocyte plasma erate rise in arterial blood pressure relative to that membranes were prepared as follows: frozen rat liver was found in the control group. The CRF-associated hyperhomogenized in 20 mM Tris-HCl (pH 7.5) containing 2 mM tension was markedly accentuated by Epo therapy MgCl 2 , 0.2 M sucrose, 5 mM phenylmethylsulphonyl fluor-consistent with the known eÂect of Epo in this model ide, 5 mg/ml leupeptin, 10 mg/ml aprotinin and 3 mg/ml [20] . Plasma total cholesterol concentration in the pepstatin A [27]. The crude extract was centrifuged at 3000 g CRF group was significantly greater than that found for 10 min at 4°C. The supernatant was then centrifuged at in the control group (P<0.001). Consistent with a 35 000 g for 30 min. The membrane preparation was then washed with the above buÂer and centrifuged at 35 000 g for previous report [16 ] , the CRF-associated elevation of 45 min at 4°C. Protein concentration was determined by serum total cholesterol was mildly but significantly using a Bio-Rad kit. One-hundred microgram protein ali-attenuated by Epo therapy. However, Epo therapy had quots were size fractionated on 4-12% Tris-glycine gel no eÂect on plasma LDL-cholesterol concentration. ( Novex Inc., San Diego, California, USA) at 120 V for 2 h. No significant diÂerence was found in hepatic microAfter electrophoresis, proteins were transferred to Hybond-somal cholesterol concentration among the study ECL membrane ( Amersham Life Science Inc., Arlington groups. found between the values obtained in the CRF and Epo-CRF groups with that found in the normal control group. As with the mRNA measurements, hepatic
Results

HMG-CoAR activities were virtually identical in the three groups.
General data
Cholesterol 7a-hydroxylase mRNA and protein mass Data are displayed in Table 1 . As expected, the CRF and EPO-CRF groups exhibited a significant increase Data are illustrated in Figures 4 and 5 . Hepatic Ch7a-H/actin mRNA values were comparable in the in plasma creatinine concentration and a significant decrease in creatinine clearance and body weight when CRF, Epo-CRF, and normal control groups. Likewise, at week 6 from NL (%), CRF (f ) and CRF/Epo (b) groups (n= 6 in each group). Data are given as mean±SEM.
no significant diÂerence was found in Ch-7a-H protein mass measurements in the three groups. impaired LDL clearance in CRF. Instead, abnormal LDL composition appears to be a more likely culprit. In fact, LDL composition has been shown to be Discussion markedly abnormal in CRF. For instance, triglyceride and Apo A-IV contents of LDL are abnormally elevated, and Apo C and Apo E, which are normally Earlier studies have revealed impaired LDL clearance in patients with chronic renal failure [28, 29] . This absent, are present in LDL particles in uraemia [5, 30] .
These compositional changes may retard receptor bindphenomenon could be due to abnormalities of LDL structure and/or limited LDL receptor availability. The ing or internalization of abnormal LDL particles, leading to impaired clearance of this lipoprotein. The CRF animals employed in the present study exhibited normal expression of hepatic LDLR mRNA and pro-observed normality of LDLR mRNA demonstrated here confirms the results recently reported by Pandak tein mass. This observation tends to argue against the role of LDLR deficiency as a main mechanism of et al. [19] . In addition the present study has provided of bile acids in the gut represent the principal pathway of cholesterol catabolism. The rate-limiting step in cholesterol conversion to bile acids is catalysed by hepatic Ch-7a-H. The CRF animals employed in the present study exhibited normal values for the Ch-7a-H mRNA and protein mass. These findings tend to exclude depressed expression of this enzyme as a contributing factor to the associated hypercholesterolaemia. In a recent study, Pandak et al. reported normal hepatic Ch-7a-H mRNA values in CRF animals 3 weeks post-nephrectomy. However, as with HMGCoAR, they found elevated Ch-7a-H enzymatic activity in their CRF animals despite normal mRNA values in the CRF animals. The observed normality of Ch7a-H protein mass can readily match the corresponding mRNA values found here and in the study reported direct quantitation of hepatocyte plasma membrane LDLR protein mass in CRF animals for the first time. by Pandak et al. [19] . Moreover, normal rate of bile acid secretion reported by these investigators can be The CRF animals studied here exhibited normal hepatic HMG-CoAR activity. This observation is con-explained based on these findings. Thus, our data point to a concordance of the mRNA and the corresponding sistent with the results of an earlier study published by Heuck et al. [6 ] . In contrast, Pandak et al. have protein in this instance. Once again, the diÂerence between the results of the two studies may be due to recently reported increased hepatic HMG-CoAR activity in spite of normal HMG-CoAR mRNA levels in the diÂerences in the chronicity of CRF, and the composition and quantity of food consumed by rats studied 3 weeks after subtotal nephrectomy [19] . The authors attributed the discrepancy between animals in the present study and those reported by Pandak et al. [19] . The lack of upregulation of Chenzyme activity and mRNA to post-transcriptional upregulation of the enzyme expression in their animals 7a-H expression in the CRF animals despite marked hypercholesterolaemia can be considered inappropriwith renal insuÃciency. The normality of HMG-CoAR mRNA found here is consistent with that found by ate. However, this phenomenon can be explained by normality of microsomal cholesterol concentration in Pandak et al. [19 ] . The reason for the variance in HMG-CoA reductase activity between the results of these animals. This is because intracellular (not extracellular) cholesterol regulates gene expression of Chthe study by Pandak et al. with those of the present study and the earlier work by Heuck et al. [6 ] is not 7a-H [17, 18] .
Liver microsomal cholesterol concentration was virentirely clear. However, the animals were studied 6 weeks following nephrectomy in the present study and tually identical in the CRF, Epo-CRF, and normal control groups. As noted above, this finding can 5 weeks post-nephrectomy by Heuck et al. as opposed to 3 weeks post-nephrectomy in the study reported by account for the normality of the gene expressions of HMG-CoAR, Ch-7a-H, and LDLR, which are largely Pandak et al. In addition, animals employed in the present study and those reported by Heuck et al. were regulated by changes of free microsomal cholesterol concentration [17, 18] . In contrast, the rats studied by fed regular rat chow ad libitum, whereas those used in the study of Pandak et al. were fed a high-protein diet Pandak et al. [19 ] 3 weeks after 75% nephrectomy had elevated hepatic microsomal cholesterol concentration. and the food intake by the controls was limited by pair-feeding with the uraemic counterparts. Thus the While uncertain, the diÂerence between the results of the two studies may be due to diÂerences in the study diÂerences in the chronicity of renal insuÃciency, dietary protein intake, and food availability to control designs noted above.
The Epo-treated CRF animals employed in the animals may account for the diÂerence observed in HMG-CoA activity in animals studied by Pandak et al. present study showed a mild reduction in serum cholesterol concentration as compared to the placebo-treated with those employed here and those used by Heuck et al. In any case, given the extent of hypercholesterola-CRF animals. This observation is consistent with the results of a recent study carried out by Pollock et al. emia in the uraemic animals, normal levels of HMGCoAR expression can be considered inappropriately [16 ] in patients with end-stage renal disease treated with maintenance dialysis. The partial reduction in high in this setting. However, the lack of appropriate downregulation of HMG-CoAR gene expression in serum cholesterol concentration in the Epo-treated animals was not accompanied by a discernible change our study can be explained by the normal concentration of microsomal cholesterol, which is the principal factor in either hepatic LDLR, HMG-CoAR or Ch-7a-H expression. Thus the mild eÂect of Epo therapy on in regulation of HMG-CoAR gene expression [17, 18] .
Conversion to bile acids and subsequent excretion serum cholesterol level does not seem to be associated
